Key result
Egr-1 negatively regulates NCX1 expression in cardiomyocytes, with Egr-1 overexpression reducing NCX1 protein to 30% of normal levels, suggesting a mechanism for its cardiac-sparing effects.
Population
Egr-1-deficient mice, wild-type mice, transgenic mice overexpressing Egr-1 in heart, and cardiac…
Comparison
Egr-1 deficiency, Egr-1 overexpression, and… vs Wild-type controls and naive controls
Design
Preclinical
Authors
Loading...
Hypothesis-generating for Egr-1-targeted therapies in catecholamine cardiomyopathy; leaves open translation beyond animal models.
Egr-1 negatively regulates NCX1 expression in cardiomyocytes, suggesting a mechanism for its protective role against catecholamine-induced cardiac damage.
Wang et al. (2004) studied Catecholamine-induced cardiac damage. Egr-1 expression vs. Wild-type or Egr-1 deficient models was evaluated on NCX1 expression. Egr-1 negatively regulates NCX1 expression in cardiomyocytes, with Egr-1 overexpression reducing NCX1 protein to 30% of normal levels, suggesting a mechanism for its cardiac-sparing effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: